Improved axillary staging of breast cancer with sentinel lymphadenectomy

Annals of Surgery

Volumn 222, Issue 3, 1995, Pages 394-401

  Giuliano, Armando E ^a   Dale, Paul S ^a   Turner, Roderick R ^a   Morton, Donald L ^a   Evans, Sheila W ^a   Krasne, David L ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER STAGING; CONFERENCE PAPER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029100686     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199509000-00016     Document Type: Conference Paper

References (17)

1. Fisher B, Wolmark N, Bauer M, et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981; 152:765-772.
2. Silverstein MJ, Gierson ED, Waisman JR, et al. Axillary lymph node dissection for T1a breast carcinoma: is it indicated? Cancer 1994; 73:664-667.
3. Morrow M. Axillary node dissection: what role in managing BCa? Contemp Oncol 1994; 4:16-27.
4. Kinne D. Controversies in primary breast cancer management. Am J Surg 1993; 166:502-508.
5. Moffat F, Senofsky G, Davis K, et al. Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol 1992; 51:8-13.
6. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 3:391-401.
7. American Joint Committee on Cancer. Breast. In: Manual for staging of cancer. 4th ed. Philadelphia: Lippincott, 1992:149-154.
8. Fisher ER, Swamidoss S, Lee CH, et al. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 1978; 42:2025-2031.
9. Kingsley WB, Peters GN, Cheek JH. What constitutes adequate study of axillary lymph nodes in breast cancer? Ann Surg 1985; 201:311-314.
10. Hainsworth PJ, Tjandra JJ, Stillwell RG, et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 1993; 80:459-463.
11. Noguchi S, Aihara T, Nakamori S, et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer 1994; 74: 1595-1600.
12. Trojani M, de Mascarel I, Bonichon F, et al. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer 1987; 55:303-306.
13. Sedmak DD, Meineke TA, Knechtges DS, Anderson J. Prognostic significance of cytokeratin-positive breast cancer metastases. Modern Pathol 1989; 2:516-520.
14. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990; 335:1565-1568.
15. Chen Z-L, Wen D-R, Coulson WF, et al. Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology. Dis Markers 1991; 9:239-248.
16. de Mascarel I, Bonichon F, Coindre JM, Trojani M. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 1992; 66:523-527.
17. Rosen PP, Saigo PE, Braun DW, et al. Axillary micro- and macro-metastases in breast cancer. Ann Surg 1981; 194:585-591.